Abstract
Abstract
Abstract Background Vancomycin dosing during intermittent hemodialysis is challenging, and access to therapeutic drug monitoring and area-under-the-curve-based dosing may be limited in resource-constrained dialysis settings. Prospective evidence on vancomycin exposure in African hemodialysis populations remains scarce. We evaluated predialysis concentrations achieved after 500- and 1000-mg post-hemodialysis dosing at a Kenyan tertiary hospital. Methods We conducted a prospective, single-centre observational study among adults receiving maintenance hemodialysis and empirical intravenous vancomycin for suspected catheter-related bloodstream infection. Participants received a post-hemodialysis dose of 500 mg or 1000 mg, as prescribed by the treating clinicians as part of routine care. Predialysis vancomycin concentrations were measured at study-designated 2-day and 3-day interdialytic intervals. Concentrations were classified relative to a study-defined reference range of 15–20 mg/L. Attainment, within-participant change, differences between dose groups, and exploratory associations with participant characteristics were evaluated. Culture results, including the organisms isolated, were summarised descriptively. Results Eighteen participants were enrolled, and 17 had evaluable concentration measurements. Mean predialysis concentrations were 8.51 mg/L (SD 5.19) and 9.52 mg/L (SD 6.04) at the 2-day and 3-day measurements, respectively. Fourteen of 17 participants (82.4%) had concentrations below 15 mg/L at each measurement, and one participant (5.9%) was within the 15–20 mg/L range at both measurements. The median paired change was + 0.60 mg/L (IQR 0.00–1.50; P = 0.002). Body weight was not associated with patient-mean concentration (Spearman ρ = 0.023; P = 0.931), and concentrations did not differ detectably between the 500- and 1000-mg groups (P = 0.397). Organisms were isolated from 12/18 participants (66.7%), all with at least one Gram-positive organism; Staphylococcus aureus was the most frequent isolate (7/18, 38.9%), and six of the seven evaluable participants with S. aureus had patient mean predialysis concentrations below 15 mg/L. Conclusions Fixed post-hemodialysis dosing frequently resulted in predialysis vancomycin concentrations below the study-defined reference range, while occasional above-range concentrations demonstrated substantial interindividual variability. Because S. aureus predominated among culture-positive participants, sustained subtherapeutic exposure is of concern not only for treatment failure but also for the selection of strains with reduced vancomycin susceptibility in hemodialysis patients. These findings support prospective evaluation of feasible concentration-guided dosing strategies for hemodialysis programmes where more sophisticated pharmacokinetic monitoring is not routinely available.
Direct answer
What can I do from this paper page?
Use this page to scan "Predialysis vancomycin target attainment after post-hemodialysis dosing in Kenya: a prospective observational study" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Antibiotics Pharmacokinetics and Efficacy research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Lubomba2026Predialysis,
title = {Predialysis vancomycin target attainment after post-hemodialysis dosing in Kenya: a prospective observational study},
author = {Witness Lubomba and Reuben Maghembe and Davis Ngarashi and Anil Fastenau and Claus A. Thomas and Benjamin Wambugu and Seth O McLigeyo and J K Kayima},
journal = {Research Square},
year = {2026},
doi = {10.21203/rs.3.rs-11444160/v1},
url = {https://doi.org/10.21203/rs.3.rs-11444160/v1}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Antibiotics Pharmacokinetics and Efficacy research papers?
Follow Antibiotics Pharmacokinetics and Efficacy research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Predialysis vancomycin target attainment after post-hemodialysis dosing in Kenya: a prospective observational study. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app